| n (%) or mean (min – max) |
---|---|
Design | |
 Randomized (Parallel) | 47 (23%) |
 Randomized (Crossover) | 95 (47%) |
 Non-randomized | 25 (12%) |
 Single-arm | 25 (12%) |
 Undefined trial | 10 (5%) |
Study Length | |
 Acute (<1 day) | 72 (36%) |
 Non-acute (≥1 day) | 123 (61%) |
Study Duration, day | |
 1–14 | 54 (44%) |
 15–30 | 21 (17%) |
 30–60 | 20 (16%) |
 60–90 | 8 (7%) |
 90–120 | 10 (8%) |
  > 120 | 10 (8%) |
 Sample Size | 45 (5–2026) |
 Age, ya | 35.4 (5–72) |
 % Malea | 62.6% |
 BMI, kg/m2a | 25.8 (18–35) |
Study Population | |
 Adults | 181 (90%) |
 Children | 11 (5%) |
 Adolescents | 3 (1.5%) |
 Mixed | 7 (3.5%) |
Baseline Health Status | |
 Healthy | 104 (52%) |
 Overweight/Obese | 24 (12%) |
 Diabetes | 51 (25%) |
 Other | 23 (11%) |